Dihydroergocryptine

DB13385InvestigationalSmall molecule

Dihydroergocryptine is a dopamine agonist indicated in the treatment of cerebrovascular diseases and atherosclerosis. A medication used to treat blood flow disorders in the brain, arms, and legs.

Resolves to

Compound

UNII67V3FSL2GL

Clinical / RWD

RxNorm3417ATCN04BC03

Targets

P34969HTR7P41595HTR2B

What you can answer from here — as of July 17, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1,069Drug interactionsStructured to mechanism, not free text

10Marketed productsAcross 3 countries and 5 labellers

1ATC codeIncluding every combination product, plus 17 drug categories

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Dihydroergocryptine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account